Advanced Wound Dressing Market Size, Share & Trends Analysis Report By Product (Foam Dressings, Film Dressings), By Application, By End-use (Hospitals, Specialty Clinics), By Region- Global Industry Analysis, Share, Growth, Regional Outlook and Forecasts, 2023-2032

The global advanced wound dressing market size was exhibited at USD 7.9 billion in 2022 and is projected to hit around USD 12.51 billion by 2032, growing at a CAGR of 4.7% during the forecast period 2023 to 2032.

Advanced Wound Dressing Market Size

Key Pointers:

  • North America dominated the advanced wound dressing industry and accounted for the largest revenue share of 45.9% in 2022.
  • Asia Pacific, the market for advanced wound dressing is anticipated to witness the fastest CAGR of 5.3% over the forecast period.  
  • The foam dressings segment dominated the market for advanced wound dressing and accounted for the largest revenue share of 23.8% in 2022.
  • The hydrocolloid dressings segment is projected to witness the fastest growth rate of CAGR of 5.8% over the forecast period. 
  • The chronic wounds segment dominated the market for advanced wound dressing and accounted for the largest share of 59.14% in 2022. 
  • The hospital segment dominated the market for advanced wound dressing and accounted for the largest revenue share of 38.12% in 2022.

Advanced Wound Dressing Market Report Scope

Report Coverage

Details

Market Size in 2023

USD 8.27 Billion

Market Size by 2032

USD 12.51 Billion

Growth Rate from 2023 to 2032

CAGR of 4.7%

Base year

2022

Forecast period

2023 to 2032

Segments covered

Product, Application, End-use

Regional scope

North America; Europe; Asia Pacific; Latin America; MEA

Key companies profiled

3M; Coloplast Corp.; Medline Industries; Smith & Nephew; ConvaTec Group PLC; Derma Sciences (Integra LifeSciences); Ethicon (Johnson & Johnson); Baxter International; Molnlycke Health Care AB; Medtronic

 

The demand for advanced wound dressing is increasing owing to technological advancements, the increasing number of surgical procedures, and the rising prevalence of chronic wounds across the globe. Increasing incidences of chronic diseases such as diabetes, cancer, and other autoimmune diseases are driving the demand for advanced wound dressings. Factors such as antimicrobial resistance, adoption of unhealthy and sedentary lifestyles, alcohol consumption, and smoking are some of the major factors contributing to the rise in the prevalence of non-communicable diseases.

According to International Diabetes Federation (IDF), 537 million individuals aged 20 to 79 are living with diabetes as of 2021, whereas, this number is predicted to increase to 643 million in 2030, and 783 million in 2045. In addition, the IDF reported that in 2021 approximately 6.9 million deaths globally were caused due to diabetes.

The increasing number of accidents, the impact of COVID-19, and technological advancements are the key driving factors for the market. The increasing incidence of accidents such as road accidents, burns, and trauma events across the globe is anticipated to drive the market. For instance, as per the WHO (2018), around 1,000,000 people are severely or moderately burnt in India per year. In addition, as per NCBI, in 2017, countries such as Bulgaria, Finland, the Netherlands, China, Australia, and the U.K. reported a rise in the incidence of burn injuries.

Furthermore, as per the American Association for the Surgery of Trauma, in 2017, around 1.2 million people died globally, accounting for the deaths of around 3,242 people per day in road accidents every year. Road accidents mostly occur in middle- or low-income countries. The advanced wound dressing is majorly used for the faster healing of all kinds of burns injuries. Moreover, bandages and gauze are also used for the treatment of minor injuries. Thus, the rising number of accidents is expected to boost the demand for advanced wound dressing, which is expected to lead to considerable market growth over the forecast period.

The rising number of surgical procedures is also expected to boost the demand for home healthcare services. According to the American Society for Metabolic and Bariatric Surgery (ASMB) in 2018, the number of people who underwent sleeve gastrectomy increased by 8.05% from 2016 to 2017 in the U.S. Patients undergoing surgeries are required to stay at hospitals for a longer period; thus, most patients prefer home healthcare services over hospital stays. Therefore, these factors are likely to boost the demand for home healthcare services, thereby fueling market growth during the forecast period.

North America dominated the advanced wound dressing industry and accounted for the largest revenue share of 45.9% in 2022. Increasing road accidents, sports injuries, and the presence of several key players in the region are anticipated to drive the market for advanced wound dressing in the region. In addition, the presence of an adequate number of skilled professionals and highly developed healthcare infrastructure is also expected to drive the market in the region over the forecast period.

In Asia Pacific, the market for advanced wound dressing is anticipated to witness the fastest CAGR of 5.3% over the forecast period. The presence of developing countries such as China, India, and Japan is anticipated to boost growth. In addition, the rapidly growing medical tourism industry in these countries can also be attributed to the increase in demand for advanced wound dressings in this region. Further, the rising geriatric population in this region is expected to drive the advanced wound dressing industry. For instance, as per the People’s Archive of Rural India, an estimated 138 million elderly population resided in India in 2019.

Some of the prominent players in the Advanced wound dressing Market include:

  • 3M
  • Coloplast Corp.
  • Medline Industries
  • Smith & Nephew
  • ConvaTec Group PLC
  • Derma Sciences (Integra LifeSciences)
  • Ethicon (Johnson & Johnson)
  • Baxter International
  • Molnlycke Heath Care AB
  • Medtronic

Segments Covered in the Report

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2032. For this study, Nova one advisor, Inc. has segmented the global advanced wound dressing market.

By Product 

  • Foam Dressings
  • Hydrocolloid Dressings
  • Film Dressings
  • Alginate Dressings
  • Hydrogel Dressings
  • Collagen Dressings
  • Other Advanced Dressings

By Application 

  • Chronic Wounds
    • Diabetic Foot Ulcers
    • Pressure Ulcers
    • Venous Leg Ulcers
    • Other Chronic Wounds
  • Acute Wounds
    • Surgical & Traumatic Wounds
    • Burns

By End-use 

  • Hospitals
  • Specialty Clinics
  • Home Healthcare
  • Physician’s Office
  • Nursing Homes
  • Others

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East & Africa (MEA)

Frequently Asked Questions

The global advanced wound dressing market size was exhibited at USD 7.9 billion in 2022 and is projected to hit around USD 12.51 billion by 2032

The global advanced wound dressing market is expected to grow at a compound annual growth rate of 4.7% from 2023 to 2032

North America dominated the advanced wound dressing market with a market share of more than 45.9% in 2022. This is attributable to the rising incidence of chronic and acute wounds.

Some key players operating in the advanced wound dressing market include Smith & Nephew Plc., Mölnlycke Health Care AB, 3M, Convatec Group PLC., Medtronic, Coloplast Corp., and Baxter.

Chapter 1 Research Methodology
                   1.1 Research Methodology
                       1.1.1 Information procurement
                   1.2 Information or Data Analysis
                   1.3 Market Formulation & Validation
                   1.4 Region-Wise Market Calculation
                       1.4.1 Region-Wise Market: Base Estimates
                       1.4.2 Global Market: CAGR Calculation
                   1.5 Region-Based Segment Share Calculation
                   1.6 Model Details
                       1.6.1 Commodity Flow Analysis (Model 1)
                       1.6.2 Volume price analysis (Model 2)
                   1.7 List of Secondary Sources
Chapter 2 Objectives
                   2.1 Objective - 1:
                   2.2 Objective - 2:
                   2.3 Objective - 3:
                   2.4 Objective - 4:
Chapter 3 Executive Summary
                   3.1 Market Outlook
                   3.2 Segment Outlook
                   3.3 Competitive Insights
                       3.3.1 Market Segmentation
                   3.4 Market Snapshot
Chapter 4 Advanced Wound Dressing Market Variables, Trends & Scope
                   4.1 Market Lineage Outlook
                       4.1.1 Parent market outlook
                       4.1.2 Ancillary Market
                   4.2 Penetration & Growth Prospect Mapping
                   4.3 Product Pipeline Analysis
                   4.4 Regulatory Framework
                   4.5 Market Dynamics
                       4.5.1 Market driver analysis
                           4.5.1.1 Global increase in the prevalence of chronic diseases
                           4.5.1.2 Increasing demand for reducing hospital stay
                           4.5.1.3 Rising number of accidents
                       4.5.2 Market restraint analysis
                           4.5.2.1 Stringent manufacturing policies
                           4.5.2.2 Rising treatment cost
                   4.6 Advanced Wound Dressing Market Analysis Tools
                       4.6.1 SWOT Analysis, by PEST
                       4.6.2 Porter’s five forces analysis
                   4.7 Major Deals & Strategic Alliances Analysis
                       4.7.1 Geographical expansion
                       4.7.2 Product launches
                   4.8 COVID-19 Market Impact
                       4.8.1 Supply chain
                       4.8.2 Changing market trends
                   4.9 Market Entry Strategies
                       4.9.1 Tapping unmet needs
Chapter 5 Advanced Wound Dressing Market: Segment Analysis, By Product, 2020 - 2032
                   5.1 Definitions & Scope
                   5.2 Product Market Share Analysis, 2023 & 2032
                   5.3 Advanced Wound Dressing Market, by Product, 2020 to 2032
                   5.4 Market Size Forecasts and Trend Analysis
                       5.4.1 Foam dressing
                           5.4.1.1 Foam dressing market, 2020 - 2032
                       5.4.2 Hydrocolloid dressing
                           5.4.2.1 Hydrocolloid dressing market, 2020 - 2032
                       5.4.3 Film dressing
                           5.4.3.1 Film dressing market, 2020 - 2032
                       5.4.4 Alginate dressing
                           5.4.4.1 Alginate dressing market, 2020 - 2032
                       5.4.5 Hydrogel dressing
                           5.4.5.1 Hydrogel dressing market, 2020 - 2032
                       5.4.6 Collagen dressing
                           5.4.6.1 Collagen dressing market, 2020 - 2032
                       5.4.7 Other advanced wound dressing
                           5.4.7.1 Other advanced wound dressing market, 2020 - 2032
Chapter 6 Advanced Wound Dressing Market: Segment Analysis, By Application, 2020 - 2032
                   6.1 Definitions & Scope
                   6.2 Application Market Share Analysis, 2023 & 2032
                   6.3 Advanced Wound Dressing Market, by Application, 2020 to 2032
                   6.4 Market Size Forecasts and Trend Analysis
                       6.4.1 Chronic wounds
                           6.4.1.1 Chronic wounds market, 2020 - 2032
                           6.4.1.2 Diabetic foot ulcers
                               6.4.1.2.1 Diabetic foot ulcers market, 2020 - 2032
                           6.4.1.3 Pressure ulcers
                               6.4.1.3.1 Pressure ulcers market, 2020 - 2032
                           6.4.1.4 Venous leg ulcers
                               6.4.1.4.1 Venous leg ulcers market, 2020 - 2032
                           6.4.1.5 Other chronic wounds
                               6.4.1.5.1 Other chronic wounds market, 2020 - 2032
                       6.4.2 Acute wounds
                           6.4.2.1 Acute wounds market, 2020 - 2032
                           6.4.2.2 Surgical & traumatic wounds
                               6.4.2.2.1 Surgical & traumatic wounds market, 2020 - 2032
                           6.4.2.3 Burn wounds
                               6.4.2.3.1 Burn wounds market, 2020 - 2032
Chapter 7 Advanced Wound Dressing Market: Segment Analysis, By End-use, 2020 - 2032
                   7.1 Definitions & Scope
                   7.2 End-use Market Share Analysis, 2023 & 2032
                   7.3 Advanced Wound Dressing Market, by End-use, 2020 to 2032
                   7.4 Market Size Forecasts and Trend Analysis
                       7.4.1 Hospitals
                           7.4.1.1 Hospitals market, 2020 - 2032
                       7.4.2 Specialty clinics
                           7.4.2.1 Specialty clinics market, 2020 - 2032
                       7.4.3 Home healthcare
                           7.4.3.1 Home healthcare market, 2020 - 2032
                       7.4.4 Physician’s Office
                           7.4.4.1 Physician’s office market, 2020 - 2032
                       7.4.5 Nursing Home
                           7.4.5.1 Nursing home market, 2020 - 2032
                       7.4.6 Other end-users
                           7.4.6.1 Other end-users market, 2020 - 2032
Chapter 8 Advanced Wound Dressing Market: Regional Market Analysis, By Product, Application, and End-use, 2020 - 2032
                   8.1 Definitions & Scope
                   8.2 Regional Market Share Analysis, 2023 & 2032
                   8.3 Regional Market Snapshot
                   8.4 Market Size Forecasts & Trend Analysis
                       8.4.1 North America
                           8.4.1.1 North America advanced wound dressing market, 2020 - 2032
                           8.4.1.2 U.S.
                               8.4.1.2.1 U.S. advanced wound dressing market, 2020 - 2032
                           8.4.1.3 Canada
                               8.4.1.3.1 Canada advanced wound dressing market, 2020 - 2032
                       8.4.2 Europe
                           8.4.2.1 Europe advanced wound dressing market, 2020 - 2032
                           8.4.2.2 U.K.
                               8.4.2.2.1 U.K. advanced wound dressing market, 2020 - 2032
                           8.4.2.3 Germany
                               8.4.2.3.1 Germany advanced wound dressing market, 2020 - 2032
                           8.4.2.4 France
                               8.4.2.4.1 France advanced wound dressing market, 2020 - 2032
                           8.4.2.5 Italy
                               8.4.2.5.1 Italy advanced wound dressing market, 2020 - 2032
                           8.4.2.6 Spain
                               8.4.2.6.1 Spain advanced wound dressing market, 2020 - 2032
                           8.4.2.7 Sweden
                               8.4.2.7.1 Sweden advanced wound dressing market, 2020 - 2032
                           8.4.2.8 Denmark
                               8.4.2.8.1 Denmark advanced wound dressing market, 2020 - 2032
                           8.4.2.9 Norway
                               8.4.2.9.1 Norway advanced wound dressing market, 2020 - 2032
                       8.4.3 Asia Pacific
                           8.4.3.1 Asia Pacific advanced wound dressing market, 2020 - 2032
                           8.4.3.2 Japan
                               8.4.3.2.1 Japan advanced wound dressing market, 2020 - 2032
                           8.4.3.3 China
                               8.4.3.3.1 China advanced wound dressing market, 2020 - 2032
                           8.4.3.4 India
                               8.4.3.4.1 India advanced wound dressing market, 2020 - 2032
                           8.4.3.5 Australia
                               8.4.3.5.1 Australia advanced wound dressing market, 2020 - 2032
                           8.4.3.6 South Korea
                               8.4.3.6.1 South Korea advanced wound dressing market, 2020 - 2032
                           8.4.3.7 Thailand
                               8.4.3.7.1 Thailand advanced wound dressing market, 2020 - 2032
                       8.4.4 Latin America
                           8.4.4.1 Latin America advanced wound dressing market, 2020 - 2032
                           8.4.4.2 Brazil
                               8.4.4.2.1 Brazil advanced wound dressing market, 2020 - 2032
                           8.4.4.3 Mexico
                               8.4.4.3.1 Mexico advanced wound dressing market, 2020 - 2032
                           8.4.4.4 Argentina
                               8.4.4.4.1 Argentina advanced wound dressing market, 2020 - 2032
                       8.4.5 Middle East & Africa
                           8.4.5.1 Middle East & Africa advanced wound dressing market, 2020 - 2032
                           8.4.5.2 South Africa
                               8.4.5.2.1 South Africa advanced wound dressing market, 2020 - 2032
                           8.4.5.3 Saudi Arabia
                               8.4.5.3.1 Saudi Arabia advanced wound dressing market, 2020 - 2032
                           8.4.5.4 UAE
                               8.4.5.4.1 UAE advanced wound dressing market, 2020 - 2032
                           8.4.5.5 Kuwait
                               8.4.5.5.1 Kuwait advanced wound dressing market, 2020 - 2032
Chapter 9 Advanced Wound Dressing Market: Competitive Analysis
                   9.1 Company Profiles
                       9.1.1 3M
                           9.1.1.1 Company overview
                           9.1.1.2 Financial performance
                           9.1.1.3 Product benchmarking
                           9.1.1.4 Strategic initiatives
                       9.1.2 Coloplast Corp.
                           9.1.2.1 Company overview
                           9.1.2.2 Financial performance
                           9.1.2.3 Product benchmarking
                           9.1.2.4 Strategic initiatives
                       9.1.3 Medline Industries
                           9.1.3.1 Company overview
                           9.1.3.2 Financial performance
                           9.1.3.3 Product benchmarking
                           9.1.3.4 Strategic initiatives
                       9.1.4 Smith & Nephew
                           9.1.4.1 Company overview
                           9.1.4.2 Financial performance
                           9.1.4.3 Product benchmarking
                           9.1.4.4 Strategic initiatives
                       9.1.5 ConvaTec Group PLC
                           9.1.5.1 Company overview
                           9.1.5.2 Financial performance
                           9.1.5.3 Product benchmarking
                           9.1.5.4 Strategic initiatives
                       9.1.6 Derma Sciences (Integra LifeSciences)
                           9.1.6.1 Company overview
                           9.1.6.2 Financial performance
                           9.1.6.3 Product benchmarking
                           9.1.6.4 Strategic initiatives
                       9.1.7 Ethicon (Johnson & Johnson)
                           9.1.7.1 Company overview
                           9.1.7.2 Financial performance
                           9.1.7.3 Product benchmarking
                           9.1.7.4 Strategic initiatives
                       9.1.8 Baxter International
                           9.1.8.1 Company overview
                           9.1.8.2 Financial performance
                           9.1.8.3 Product benchmarking
                           9.1.8.4 Strategic initiatives
                       9.1.9 Molnlycke Health Care AB
                           9.1.9.1 Company overview
                           9.1.9.2 Financial performance
                           9.1.9.3 Product benchmarking
                           9.1.9.4 Strategic initiatives
                       9.1.10 Medtronic
                           9.1.10.1 Company overview
                           9.1.10.2 Financial performance
                           9.1.10.3 Product benchmarking
                           9.1.10.4 Strategic initiatives

Proceed To Buy

USD 4500
USD 3800
USD 1900
USD 1200

Customization Offered

  • check-imgCross-segment Market Size and Analysis for Mentioned Segments
  • check-imgAdditional Company Profiles (Upto 5 With No Cost)
  • check-img Additional Countries (Apart From Mentioned Countries)
  • check-img Country/Region-specific Report
  • check-img Go To Market Strategy
  • check-imgRegion Specific Market Dynamics
  • check-imgRegion Level Market Share
  • check-img Import Export Analysis
  • check-imgProduction Analysis
  • check-imgOthers